U 787 (Glipizide and Metformin 2.5 mg / 250 mg)
Pill imprint U 787 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 2.5 mg / 250 mg
- Prescription only
hypromellose 2910 (15 mPa.s)
polyethylene glycol 6000
ferric oxide red
More about glipizide/metformin
- Other brands: Metaglip
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.